BAILARD, INC. - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 167 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.2%.

Quarter-by-quarter ownership
BAILARD, INC. ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q2 2021$212,000
-67.1%
10,000
-56.5%
0.01%
-70.8%
Q1 2021$645,000
+7.9%
23,0000.0%0.02%
-11.1%
Q4 2020$598,000
-83.7%
23,000
-76.6%
0.03%
-85.8%
Q3 2020$3,661,000
-27.6%
98,5000.0%0.19%
-32.6%
Q2 2020$5,054,000
+71.8%
98,500
+5.6%
0.28%
+34.3%
Q1 2020$2,942,000
-46.9%
93,300
-42.0%
0.21%
-32.7%
Q4 2019$5,538,000
+66.2%
160,900
+77.0%
0.31%
+55.2%
Q3 2019$3,332,000
-6.0%
90,900
+19.3%
0.20%
-7.4%
Q2 2019$3,545,000
+48.4%
76,200
+28.1%
0.22%
+46.6%
Q1 2019$2,389,000
+477.1%
59,500
+561.1%
0.15%
+428.6%
Q4 2018$414,000
+3.8%
9,0000.0%0.03%
+21.7%
Q3 2018$399,000
+13.0%
9,0000.0%0.02%
+9.5%
Q2 2018$353,000
-92.3%
9,000
-92.0%
0.02%
-92.9%
Q1 2018$4,609,000
-7.0%
112,600
+49.5%
0.29%
-5.8%
Q4 2017$4,958,000
+56.3%
75,300
+19.0%
0.31%
+26.8%
Q3 2017$3,173,000
+8.3%
63,3000.0%0.25%
+3.4%
Q2 2017$2,930,000
+102.3%
63,300
+54.4%
0.24%
+98.3%
Q1 2017$1,448,000
+624.0%
41,000
+355.6%
0.12%
+34.8%
Q4 2015$200,0009,0000.09%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q1 2020
NameSharesValueWeighting ↓
Meditor Group Ltd 2,818,835$59,618,00021.09%
Bellevue Group AG 4,519,164$95,580,0000.93%
PLATINUM INVESTMENT MANAGEMENT LTD 1,713,176$36,234,0000.84%
Rhenman & Partners Asset Management AB 572,267$12,103,0000.82%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 64,434$1,363,0000.45%
Boxer Capital, LLC 500,000$10,575,0000.37%
EMC Capital Management 27,566$583,0000.33%
WASATCH ADVISORS LP 3,766,935$79,671,0000.32%
Avidity Partners Management LP 400,000$8,460,0000.23%
Cinctive Capital Management LP 186,170$3,937,0000.18%
View complete list of ESPERION THERAPEUTICS INC NE shareholders